GMED · Globus Medical Inc. Class A Common Stock
View on chartInsiders & Stakes
| David D. Davidar Director | ▼ Sell | Gift | 507,675 Shares held | 7/27/2026 | View profile |
| David C. Paul Executive Chairman | ▲ Buy | Option Exercise | 60,417 Shares held | 12/8/2025 | View profile |
| Ann D. Rhoads Director | ▲ Buy | Option Exercise | 40,384 Shares held | 6/4/2026 | View profile |
| Wolterman Dan Director | ▲ Buy | Grant | 24,025 Shares held | 9/1/2023 | View profile |
| DeFord John A Director | ▲ Buy | Grant | 15,578 Shares held | 9/1/2023 | View profile |
| Leslie Norwalk V Director | ▼ Sell | Open Market | 10,419 Shares held | 1/8/2026 | View profile |
| Kelly Huller SVP, GC, Corporate Secretary | ▼ Sell | Open Market | 0 Shares held | 2/25/2026 | View profile |
| Kyle Kline Senior Vice President, CFO | ▼ Sell | Open Market | 0 Shares held | 1/8/2026 | View profile |
| Stephen T. Zarrilli Director | ▼ Sell | Open Market | 0 Shares held | 8/18/2026 | View profile |
| Daniel T. Scavilla Director | ▼ Sell | Open Market | 0 Shares held | 11/21/2024 | View profile |
| Pfeil Keith W SVP, Chief Financial Officer | ▼ Sell | Open Market | 0 Shares held | 1/10/2025 | View profile |
| Lemaitre Dan Director | ▼ Sell | Open Market | 0 Shares held | 11/22/2024 | View profile |
| TOBIN JAMES R Director | ▼ Sell | Open Market | 0 Shares held | 9/15/2026 | View profile |
Transaction History
| TOBIN JAMES R | ▲ Buy | Option Exercise | 15,000 | $806K | 9/15/2026 |
| TOBIN JAMES R | ▲ Buy | Option Exercise | 15,000 | $955K | 9/15/2026 |
| TOBIN JAMES R | ▼ Sell | Open Market | 30,000 | $2.2M | 9/15/2026 |
| Stephen T. Zarrilli | ▲ Buy | Option Exercise | 25,000 | $1.3M | 8/18/2026 |
| Stephen T. Zarrilli | ▼ Sell | Open Market | 25,000 | $2.2M | 8/18/2026 |
| David D. Davidar | ▼ Sell | Gift | 2,500 | $0 | 7/27/2026 |
| David D. Davidar | ▲ Buy | Option Exercise | 25,000 | $657K | 6/5/2026 |
| David D. Davidar | ▼ Sell | Open Market | 25,000 | $2.0M | 6/5/2026 |
| Ann D. Rhoads | ▲ Buy | Option Exercise | 25,000 | $657K | 6/4/2026 |
| Kelly Huller | ▲ Buy | Option Exercise | 20,000 | $872K | 2/25/2026 |
| Kelly Huller | ▼ Sell | Open Market | 20,000 | $1.9M | 2/25/2026 |
| Kelly Huller | ▲ Buy | Option Exercise | 10,000 | $456K | 2/12/2026 |
| Kelly Huller | ▼ Sell | Open Market | 10,000 | $877K | 2/12/2026 |
| Kyle Kline | ▲ Buy | Option Exercise | 3,594 | $186K | 1/8/2026 |
| Kyle Kline | ▼ Sell | Open Market | 3,594 | $363K | 1/8/2026 |
| Leslie Norwalk V | ▼ Sell | Open Market | 2,000 | $202K | 1/8/2026 |
| Leslie Norwalk V | ▼ Sell | Open Market | 4,000 | $355K | 12/12/2025 |
| David C. Paul | ▲ Buy | Option Exercise | 34,375 | $877K | 12/8/2025 |
| Kyle Kline | ▲ Buy | Option Exercise | 3,646 | $194K | 12/1/2025 |
| Kyle Kline | ▲ Buy | Option Exercise | 5,000 | $322K | 12/1/2025 |
| Kyle Kline | ▲ Buy | Option Exercise | 4,896 | $312K | 12/1/2025 |
| Kyle Kline | ▼ Sell | Open Market | 18,542 | $1.7M | 12/1/2025 |
| Kyle Kline | ▲ Buy | Option Exercise | 5,000 | $282K | 12/1/2025 |
| Kelly Huller | ▲ Buy | Option Exercise | 7,500 | $195K | 11/25/2025 |
| Kelly Huller | ▼ Sell | Open Market | 7,500 | $675K | 11/25/2025 |
| David D. Davidar | ▲ Buy | Option Exercise | 25,000 | $638K | 11/12/2025 |
| David D. Davidar | ▼ Sell | Open Market | 25,000 | $2.2M | 11/12/2025 |
| Stephen T. Zarrilli | ▲ Buy | Option Exercise | 25,000 | $1.1M | 11/11/2025 |
| Stephen T. Zarrilli | ▼ Sell | Open Market | 25,000 | $2.1M | 11/11/2025 |
| Ann D. Rhoads | ▼ Sell | Open Market | 2,000 | $170K | 11/10/2025 |
| Ann D. Rhoads | ▼ Sell | Open Market | 8,000 | $648K | 11/7/2025 |
| Ann D. Rhoads | ▼ Sell | Open Market | 10,000 | $585K | 9/15/2025 |
| Ann D. Rhoads | ▼ Sell | Open Market | 7,500 | $590K | 2/28/2025 |
| Pfeil Keith W | ▼ Sell | Open Market | 1,666 | $149K | 1/10/2025 |
| Pfeil Keith W | ▲ Buy | Option Exercise | 5,833 | $290K | 1/10/2025 |
| Pfeil Keith W | ▲ Buy | Option Exercise | 8,334 | $444K | 1/10/2025 |
| Pfeil Keith W | ▼ Sell | Open Market | 12,501 | $1.1M | 1/10/2025 |
| David D. Davidar | ▼ Sell | Gift | 6,100 | $0 | 1/2/2025 |
| Kelly Huller | ▲ Buy | Option Exercise | 2,500 | $61K | 12/2/2024 |
| Kelly Huller | ▼ Sell | Open Market | 2,500 | $218K | 12/2/2024 |
| David D. Davidar | ▼ Sell | Open Market | 6,766 | $575K | 11/22/2024 |
| David D. Davidar | ▼ Sell | Open Market | 6,746 | $573K | 11/22/2024 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 1,097 | $71K | 11/22/2024 |
| Lemaitre Dan | ▼ Sell | Open Market | 1,097 | $93K | 11/22/2024 |
| David D. Davidar | ▼ Sell | Open Market | 13,234 | $1.1M | 11/21/2024 |
| David D. Davidar | ▼ Sell | Open Market | 13,254 | $1.1M | 11/21/2024 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 13,278 | $864K | 11/21/2024 |
| Lemaitre Dan | ▼ Sell | Open Market | 13,278 | $1.1M | 11/21/2024 |
| Daniel T. Scavilla | ▲ Buy | Option Exercise | 50,000 | $2.2M | 11/21/2024 |
| Daniel T. Scavilla | ▼ Sell | Open Market | 130,000 | $11.1M | 11/21/2024 |
| Daniel T. Scavilla | ▲ Buy | Option Exercise | 80,000 | $3.5M | 11/21/2024 |
| David C. Paul | ▲ Buy | Option Exercise | 26,042 | $628K | 11/15/2024 |
| Daniel T. Scavilla | ▲ Buy | Option Exercise | 30,000 | $1.3M | 11/6/2024 |
| Kelly Huller | ▼ Sell | Open Market | 2,500 | $205K | 11/6/2024 |
| Daniel T. Scavilla | ▼ Sell | Open Market | 60,000 | $4.8M | 11/6/2024 |
| Kelly Huller | ▼ Sell | Open Market | 2,500 | $200K | 11/6/2024 |
| Kelly Huller | ▲ Buy | Option Exercise | 5,000 | $121K | 11/6/2024 |
| Daniel T. Scavilla | ▲ Buy | Option Exercise | 30,000 | $788K | 11/6/2024 |
| Kelly Huller | ▲ Buy | Option Exercise | 7,500 | $194K | 10/16/2024 |
| Kelly Huller | ▼ Sell | Open Market | 7,500 | $563K | 10/16/2024 |
| David D. Davidar | ▼ Sell | Open Market | 20,000 | $1.5M | 10/16/2024 |
| David D. Davidar | ▼ Sell | Open Market | 30,000 | $2.3M | 10/16/2024 |
| Ann D. Rhoads | ▲ Buy | Option Exercise | 15,000 | $362K | 9/13/2024 |
| Ann D. Rhoads | ▲ Buy | Option Exercise | 20,000 | $510K | 9/13/2024 |
| Ann D. Rhoads | ▼ Sell | Open Market | 15,000 | $1.1M | 9/13/2024 |
| David D. Davidar | ▲ Buy | Option Exercise | 25,000 | $638K | 9/13/2024 |
| David D. Davidar | ▼ Sell | Open Market | 25,000 | $1.8M | 9/13/2024 |
| Leslie Norwalk V | ▼ Sell | Open Market | 1,000 | $70K | 7/11/2024 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 17,500 | $766K | 5/10/2024 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 17,500 | $932K | 5/10/2024 |
| Lemaitre Dan | ▼ Sell | Open Market | 63,300 | $4.1M | 5/10/2024 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 17,500 | $763K | 5/10/2024 |
| David D. Davidar | ▼ Sell | Open Market | 20,000 | $1.3M | 5/8/2024 |
| Leslie Norwalk V | ▼ Sell | Open Market | 10,590 | $551K | 3/15/2024 |
| Kelly Huller | ▲ Buy | Option Exercise | 7,500 | $187K | 3/1/2024 |
| Kelly Huller | ▼ Sell | Open Market | 4,385 | $236K | 3/1/2024 |
| Kelly Huller | ▼ Sell | Open Market | 3,115 | $170K | 3/1/2024 |
| David D. Davidar | ▼ Sell | Gift | 8,000 | $0 | 1/18/2024 |
| Leslie Norwalk V | ▲ Buy | Grant | 25,688 | — | 9/1/2023 |
| DeFord John A | ▲ Buy | Grant | 15,578 | — | 9/1/2023 |
| Leslie Norwalk V | ▲ Buy | Grant | 2,321 | — | 9/1/2023 |
| Wolterman Dan | ▲ Buy | Grant | 24,025 | — | 9/1/2023 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 1,450 | $35K | 5/15/2023 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 10,500 | $253K | 5/15/2023 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 14,000 | $357K | 5/15/2023 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 17,500 | $460K | 5/15/2023 |
| Lemaitre Dan | ▼ Sell | Open Market | 43,450 | $2.5M | 5/15/2023 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 5,550 | $133K | 2/9/2023 |
| Pfeil Keith W | ▲ Buy | Option Exercise | 15,000 | $799K | 2/2/2023 |
| Pfeil Keith W | ▲ Buy | Option Exercise | 14,167 | $703K | 2/2/2023 |
| Pfeil Keith W | ▼ Sell | Open Market | 29,167 | $2.3M | 2/2/2023 |
| Ann D. Rhoads | ▲ Buy | Option Exercise | 7,500 | $94K | 1/27/2023 |
| Lemaitre Dan | ▲ Buy | Option Exercise | 5,250 | $66K | 1/27/2023 |
| Kelly Huller | ▲ Buy | Option Exercise | 7,500 | $94K | 12/1/2022 |
| Kelly Huller | ▼ Sell | Open Market | 7,500 | $563K | 12/1/2022 |
| David D. Davidar | ▼ Sell | Open Market | 31,500 | $2.5M | 4/19/2022 |
| Kelly Huller | ▼ Sell | Open Market | 2,500 | $189K | 4/8/2022 |
| Kelly Huller | ▲ Buy | Option Exercise | 2,500 | $38K | 4/8/2022 |
| TOBIN JAMES R | ▲ Buy | Option Exercise | 3,542 | $189K | 3/15/2022 |
| TOBIN JAMES R | ▲ Buy | Option Exercise | 5,308 | $231K | 3/15/2022 |
| TOBIN JAMES R | ▼ Sell | Open Market | 8,850 | $579K | 3/15/2022 |
| David D. Davidar | ▼ Sell | Gift | 7,000 | $0 | 3/14/2022 |
| TOBIN JAMES R | ▲ Buy | Option Exercise | 10,000 | $436K | 3/10/2022 |
| TOBIN JAMES R | ▼ Sell | Open Market | 10,000 | $700K | 3/10/2022 |
| TOBIN JAMES R | ▲ Buy | Option Exercise | 4,484 | $195K | 3/8/2022 |
| TOBIN JAMES R | ▼ Sell | Open Market | 4,484 | $323K | 3/8/2022 |
| David D. Davidar | ▼ Sell | Gift | 2,000 | $0 | 9/8/2021 |
| Pfeil Keith W | ▲ Buy | Option Exercise | 833 | $44K | 8/19/2021 |
| Pfeil Keith W | ▼ Sell | Open Market | 833 | $63K | 8/19/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
RBC Lowers Globus Medical Price Target to $85
RBC Capital has lowered its price target for Globus Medical to $85 while maintaining an Outperform rating. This move comes as the company navigates industry challenges, with recent attention on how medical device firms are using generative AI to manage costs and operations. The stock is currently trading below the average analyst target of $100.92, reflecting a cautious outlook from some investors despite the firm's positive stance.
RBC Lowers Globus Medical Price Target to $85. RBC Capital has lowered its price target for Globus Medical to $85 while maintaining an Outperform rating. This move comes as the company navigates industry challenges, with recent attention on how medical device firms are using generative AI to manage costs and operations. The stock is currently trading below the average analyst target of $100.92, reflecting a cautious outlook from some investors despite the firm's positive stance.